Trial
NCT04504734
Bucillamine in Treatment of Patients With COVID-19
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Revive Therapeutics, Ltd.
Collaborators
—
Condition
Covid19
Intervention
Bucillamine
Why stopped
Met definition of futility according to DSMB
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-07-07